These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1003 related articles for article (PubMed ID: 28135077)

  • 1. Mechanistic Understanding of Lanthipeptide Biosynthetic Enzymes.
    Repka LM; Chekan JR; Nair SK; van der Donk WA
    Chem Rev; 2017 Apr; 117(8):5457-5520. PubMed ID: 28135077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanistic aspects of lanthipeptide leaders.
    Plat A; Kuipers A; Rink R; Moll GN
    Curr Protein Pept Sci; 2013 Mar; 14(2):85-96. PubMed ID: 23441895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure and mechanism of lanthipeptide biosynthetic enzymes.
    van der Donk WA; Nair SK
    Curr Opin Struct Biol; 2014 Dec; 29():58-66. PubMed ID: 25460269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Michael-type cyclizations in lantibiotic biosynthesis are reversible.
    Yang X; van der Donk WA
    ACS Chem Biol; 2015 May; 10(5):1234-8. PubMed ID: 25723375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural Analysis of Class I Lanthipeptides from
    Bothwell IR; Caetano T; Sarksian R; Mendo S; van der Donk WA
    ACS Chem Biol; 2021 Jun; 16(6):1019-1029. PubMed ID: 34085816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peptide backbone modifications in lanthipeptides.
    Ayikpoe RS; van der Donk WA
    Methods Enzymol; 2021; 656():573-621. PubMed ID: 34325799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unexpected Methyllanthionine Stereochemistry in the Morphogenetic Lanthipeptide SapT.
    Sarksian R; Hegemann JD; Simon MA; Acedo JZ; van der Donk WA
    J Am Chem Soc; 2022 Apr; 144(14):6373-6382. PubMed ID: 35352944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanistic Studies on Dehydration in Class V Lanthipeptides.
    Liang H; Lopez IJ; Sánchez-Hidalgo M; Genilloud O; van der Donk WA
    ACS Chem Biol; 2022 Sep; 17(9):2519-2527. PubMed ID: 36044589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deciphering the Biosynthesis of Novel Class I Lanthipeptides from Marine
    Wang X; Wang Z; Dong Z; Yan Y; Zhang Y; Huo L
    ACS Chem Biol; 2023 May; 18(5):1218-1227. PubMed ID: 37162177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro catalytic activity of N-terminal and C-terminal domains in NukM, the post-translational modification enzyme of nukacin ISK-1.
    Shimafuji C; Noguchi M; Nishie M; Nagao J; Shioya K; Zendo T; Nakayama J; Sonomoto K
    J Biosci Bioeng; 2015 Dec; 120(6):624-9. PubMed ID: 25971839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Engineering dehydro amino acids and thioethers into peptides using lacticin 481 synthetase.
    Chatterjee C; Patton GC; Cooper L; Paul M; van der Donk WA
    Chem Biol; 2006 Oct; 13(10):1109-17. PubMed ID: 17052615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved lanthipeptide detection and prediction for antiSMASH.
    Blin K; Kazempour D; Wohlleben W; Weber T
    PLoS One; 2014; 9(2):e89420. PubMed ID: 24586765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nine post-translational modifications during the biosynthesis of cinnamycin.
    Ökesli A; Cooper LE; Fogle EJ; van der Donk WA
    J Am Chem Soc; 2011 Aug; 133(34):13753-60. PubMed ID: 21770392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigation of the substrate specificity of lacticin 481 synthetase by using nonproteinogenic amino acids.
    Levengood MR; Kerwood CC; Chatterjee C; van der Donk WA
    Chembiochem; 2009 Mar; 10(5):911-9. PubMed ID: 19222036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery and Characterization of a Class IV Lanthipeptide with a Nonoverlapping Ring Pattern.
    Ren H; Shi C; Bothwell IR; van der Donk WA; Zhao H
    ACS Chem Biol; 2020 Jun; 15(6):1642-1649. PubMed ID: 32356655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dissecting reactions of nonlinear precursor peptide processing of the class III lanthipeptide curvopeptin.
    Jungmann NA; Krawczyk B; Tietzmann M; Ensle P; Süssmuth RD
    J Am Chem Soc; 2014 Oct; 136(43):15222-8. PubMed ID: 25291240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutations in Dynamic Structural Elements Alter the Kinetics and Fidelity of the Multifunctional Class II Lanthipeptide Synthetase, HalM2.
    Uggowitzer KA; Habibi Y; Wei W; Moitessier N; Thibodeaux CJ
    Biochemistry; 2021 Feb; 60(5):412-430. PubMed ID: 33507068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improving the attrition rate of Lanthipeptide discovery for commercial applications.
    Geng M; Smith L
    Expert Opin Drug Discov; 2018 Feb; 13(2):155-167. PubMed ID: 29195488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Substrate Recognition by the Class II Lanthipeptide Synthetase HalM2.
    Rahman IR; Acedo JZ; Liu XR; Zhu L; Arrington J; Gross ML; van der Donk WA
    ACS Chem Biol; 2020 Jun; 15(6):1473-1486. PubMed ID: 32293871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Structural View on the Maturation of Lanthipeptides.
    Lagedroste M; Reiners J; Knospe CV; Smits SHJ; Schmitt L
    Front Microbiol; 2020; 11():1183. PubMed ID: 32582108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 51.